Product containing teprotumumab (medicinal product)
RxNorm 2274803
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2274803 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing teprotumumab (medicinal product).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing teprotumumab (medicinal product)
(Atom ID: 12421887)
INPrescribable
Ingredient (IN):
Teprotumumab
(Atom ID: 12776840)
PTPrescribable
Designated preferred name (PT):
Teprotumumab
(Atom ID: 12422080)
FNPrescribable
Full form of descriptor (FN):
Teprotumumab (substance)
(Atom ID: 12422081)
PTPrescribable
Designated preferred name (PT):
Teprotumumab-containing product
(Atom ID: 12422084)
Patient Education
Teprotumumab-trbw Injection
Teprotumumab-trbw injection is used to treat thyroid eye disease (TED; Graves' eye disease; a disorder in which the immune system causes inflammation and swelling behind the eye). Teprotumumab-trbw is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain protein in the body that causes inflammation in the eye.
[Learn More]
* Please review the disclaimer below.